Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2022-06-17$4.99/sh−4,552$22,719→ 190,165 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.